The prevalence of multiple sclerosis (MS) vanes throughout the world. For example, Europe, Canada, and the northern part of the United States of America are areas of high prevalence, whereas Asia, Africa, and the West Indies are apparently areas of low prevalence. Those who migrate from a high-risk to a low-risk area keep their high risk unless they migrate when they are under 16 (Dean, 1967; Dean and Kurtzke, 1971 ).
Previous reports have suggested that the prevalence of MS in Sicily is very low-for example, 3-3 per 100 000 in Palermo city (Societa Italiana di Neurologia, 1975) -but these were studies of large populations. The high prevalence of MS among Italian immigrants living in London suggests that the prevalence of MS in Italy as a whole is not greatly different from that in the United Kingdom (Dean et al., 1976; (Table) . In addition, there were two patients with a diagnosis of possible MS only.
Paraparesis was the first symptom in seven patients, paraesthesia in three patients, and impairment of vision in three. The remaining two patients presented with attacks of vertigo or of sciatic pain. The average age of the three men in the study on prevalence day was 36-3 and of the 12 women 37-5. The average age of onset was 26-4 and one patient had her first symptoms at the age of 8, another at 15. Fourteen of the 15 patients had at least partial remissions and only one patient (No. 1 in the 'females' section of the Table) Studying the history and the clinical condition of the patients presented to us with identifiable disease, we were struck by the fact that MS appears to pursue a less benign course in this part of Europe. For example, all three men examined had a fixed disability, the first after six years, the second after an unidentifiable period, and the third after 10 years. Of the 12 women in the study, two (cases 5 and 6) had long remissions, one of 20 years and the other of 22 years. Only five of the 12 had had complete remissions. Ten of the 12 women had a fixed disability at an average time of just over six years after the onset of the illness and, if the two women with long remissions were included, at less than 10 years. This is quite contrary to usual experience in the north of Europe, where one would expect to find no evidence of disability whatsoever in over 50% of patients examined six years after the commencement of the illness nor in very nearly half of the patients when examined 10 years after the commencement. Of 335 patients seen consecutively by one of the authors (R.K.), 183 had a history going back for a minimum of 10 years without developing a fixed disability, and 74 (more than one-fifth of the total) had such a history going back more than 20 years (Kelly, 1972) . We may, of course, have overlooked some patients in Enna with complete remissions and a more benign course.
The minimum prevalence of MS in Enna city, 53 per 100 000, is of the same order of magnitude as has been found in studies in northern Europe; for example, the reported prevalence of MS in Northern Ireland is 64 and in the Republic of Ireland 65 per 100 000 (Millar, 1971; Brady et al., 1977 
